ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 171 filers reported holding ANI PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,061,130 | +18.2% | 35,500 | +9.6% | 0.00% | +100.0% |
| Q2 2023 | $1,744,092 | +55.7% | 32,400 | +14.9% | 0.00% | 0.0% |
| Q1 2023 | $1,120,104 | -11.6% | 28,200 | -10.5% | 0.00% | 0.0% |
| Q4 2022 | $1,267,245 | +28.4% | 31,500 | +2.6% | 0.00% | 0.0% |
| Q3 2022 | $987,000 | +12.4% | 30,700 | +3.7% | 0.00% | 0.0% |
| Q2 2022 | $878,000 | +15.7% | 29,600 | +9.6% | 0.00% | – |
| Q1 2022 | $759,000 | -34.6% | 27,000 | +7.1% | 0.00% | -100.0% |
| Q4 2021 | $1,161,000 | +57.3% | 25,200 | +12.0% | 0.00% | – |
| Q3 2021 | $738,000 | -3.4% | 22,500 | +3.2% | 0.00% | – |
| Q2 2021 | $764,000 | -5.7% | 21,800 | -2.7% | 0.00% | -100.0% |
| Q1 2021 | $810,000 | +24.6% | 22,400 | 0.0% | 0.00% | – |
| Q4 2020 | $650,000 | +2.8% | 22,400 | 0.0% | 0.00% | – |
| Q3 2020 | $632,000 | -9.6% | 22,400 | +3.7% | 0.00% | -100.0% |
| Q2 2020 | $699,000 | -1.4% | 21,600 | +24.1% | 0.00% | 0.0% |
| Q1 2020 | $709,000 | -33.9% | 17,400 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $1,073,000 | -13.4% | 17,400 | +2.4% | 0.00% | 0.0% |
| Q3 2019 | $1,239,000 | -8.6% | 17,000 | +3.0% | 0.00% | 0.0% |
| Q2 2019 | $1,356,000 | +18.6% | 16,500 | +1.9% | 0.00% | 0.0% |
| Q1 2019 | $1,143,000 | +61.7% | 16,200 | +3.2% | 0.00% | 0.0% |
| Q4 2018 | $707,000 | -15.5% | 15,700 | +6.1% | 0.00% | 0.0% |
| Q3 2018 | $837,000 | -15.4% | 14,800 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $989,000 | +14.7% | 14,800 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $862,000 | -9.6% | 14,800 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $954,000 | +22.8% | 14,800 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $777,000 | +12.1% | 14,800 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $693,000 | -5.5% | 14,800 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $733,000 | -18.3% | 14,800 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $897,000 | -8.7% | 14,800 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $982,000 | +18.9% | 14,800 | 0.0% | 0.00% | +100.0% |
| Q2 2016 | $826,000 | +84.0% | 14,800 | +7.2% | 0.00% | 0.0% |
| Q1 2016 | $449,000 | -12.0% | 13,800 | +22.1% | 0.00% | 0.0% |
| Q4 2015 | $510,000 | +14.3% | 11,300 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $446,000 | -27.4% | 11,300 | +14.1% | 0.00% | -50.0% |
| Q2 2015 | $614,000 | – | 9,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 200,000 | $13,270,000 | 21.02% |
| Healthcare Value Capital, LLC | 50,000 | $3,318,000 | 5.26% |
| Consonance Capital Management LP | 653,258 | $43,344,000 | 4.17% |
| 1492 Capital Management LLC | 34,500 | $2,289,000 | 1.87% |
| JW Asset Management, LLC | 29,722 | $1,972,000 | 1.36% |
| FRANKLIN STREET ADVISORS INC /NC | 29,000 | $1,924,000 | 0.35% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 55,705 | $3,696,000 | 0.27% |
| Ativo Capital Management LLC | 15,805 | $1,049,000 | 0.24% |
| DIKER MANAGEMENT LLC | 9,810 | $651,000 | 0.23% |
| CASTLEARK MANAGEMENT LLC | 100,615 | $6,676,000 | 0.20% |